X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

F1000Research

期刊標題檢索 最新評論: Always feel that the innovative submission, review, and publication mo... (2022-09-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[F1000Research]您好,您是該頁面的第 15643 位訪客。

期刊簡介
期刊名稱F1000Research F1000Research

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
8.2
50 ratings
Rate

Reputation
8.0

Influence
8.3

Speed
7.9

期刊簡稱
ISSN2046-1402
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.000.8210.787
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q196 / 636
Category: Medicine
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q113 / 80
Category: Medicine
Subcategory: General Immunology and Microbiology
Q221 / 61
Category: Medicine
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q278 / 221

自引率 (2023-2024)N.A.自引率趨勢
掲載範囲
F1000Research provides a platform to publish all forms of research in the physical and life sciences, engineering, medicine, social sciences and humanities, ranging from research articles to software tool articles, as well as many other formats including posters and lecture slides.
官方網站https://f1000research.com/
在線稿件提交https://f1000research.com/for-authors/publish-your-research
開放訪問Yes
出版商Taylor & Francis
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區United Kingdom
發行頻率
創刊年0
每年文章數0每年文章數趨勢
黃金OA百分比0.00%
OA Related Info
APC: Yes( USD1350; )
APC waiver:Check Notes
Other charges: No
Keywords: life sciences、physical sciences、medicine、engineering、social sciences、humanities
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q0

N/A
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2046-1402%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 1 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【F1000Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Reports in Pharmaceutical SciencesH-index: 0

    CiteScore: 1.40
    Chinese Journal of New DrugsH-index: 0

    CiteScore: 0.30
    Hacettepe University Journal of the Faculty of PharmacyH-index: 0

    CiteScore: 0.60
    Azerbaijan Pharmaceutical and Pharmacotherapy JournalH-index: 0

    CiteScore: 0.40
    African Journal Biomedical ResearchH-index: 0

    CiteScore: 0.50
    Journal of Applied Pharmaceutical ScienceH-index: 0

    CiteScore: 2.20
    Journal of Pharmacy and Nutrition SciencesH-index: 0

    CiteScore: 0.70
    Drug Metabolism and Personalized TherapyH-index: 0

    CiteScore: 2.30
    European Pharmaceutical JournalH-index: 0

    CiteScore: 0.60
    Pharmaceutical Sciences AsiaH-index: 0

    CiteScore: 0.90
    學科內最受檢索的期刊 頁面查看次數
    Journal of Applied Pharmaceutical Science3095
    Current Bioactive Compounds3048
    Handbook of Experimental Pharmacology2382
    Journal of Pharmacy and Nutrition Sciences2102
    Zhongguo Zhongyao Zazhi2078
    Yaoxue Xuebao1981
    Chinese Journal of New Drugs1871
    Pharmaceutical Sciences Asia1691
    Journal of Reports in Pharmaceutical Sciences1651
    Drug Metabolism and Personalized Therapy1605
  •  

    F1000Research F1000Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [F1000Research] 的評論撰寫評論
作者: 帖拉所伊朵


領域: 社会科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-27 09:30:09 評論於
Always feel that the innovative submission, review, and publication model of this journal (F1000Research) is the future trend.
(0) 讚! | 帖拉所伊朵

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [F1000Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*